Publication | Open Access
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
140
Citations
8
References
2020
Year
The results of this case series suggest that high-dose oral famotidine is well tolerated and associated with improved patient-reported outcomes in non-hospitalised patients with COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1